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Metastatic renal cell carcinoma in the gallbladder is extremely rare, with reported frequencies of less than 0.6% in
large autopsy reviews. Only 40 cases were reported in the literature. We report a first case of gallbladder polypoid
tumor revealing metastatic clear cell renal cell carcinoma, which demonstrates the importance of radiological tests,
histology and immunohistochemistry when making a definitive diagnosis. These examinations also allow
differentiating metastatic clear cell renal cell carcinoma from other polypoid lesions in the gallbladder with clear
cell morphology. Cholecystectomy should be performed to obtain a definitive diagnosis and to improve survival in
case of solitary metastatic renal cell carcinoma.
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Metastatic tumors to the gallbladder are uncommon. The
most common metastatic tumors to the gallbladder are
metastatic melanomas and metastatic carcinomas from
stomach, pancreas, ovary, bile ducts, colon and breast [1].
Metastatic renal cell carcinoma in the gallbladder is ex-
tremely rare, with reported frequencies of less than 0.6%
in large autopsy reviews [2]. Renal cell carcinoma is a rare
tumor accounting for 3% of all malignancies in adults and
85% of primary renal tumors. However, this tumor has a
great propensity for metastasizing synchronously or meta-
chronously to various anatomic sites [3]. We report a case
of intraluminal polypoid metastasis of clear cell renal cell
carcinoma in gallbladder mimicking gallbladder polyp and
revealing the renal carcinoma and reviewed the reported
40 cases. The clinico-pathologic features and differential
diagnosis are discussed.* Correspondence: merighaouti@live.fr
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Case report
A 55-year-old woman presented with severe right hypo-
chondrium pain, with weight loss and alteration of her
general condition, lasting for 6 months. She showed no
urological signs, especially no hematuria, no pain, and
no flank mass. She had no past history in particular. Nei-
ther physical examination nor laboratory examination
revealed any significant findings. Abdominal ultrasonog-
raphy showed a 2.6 cm diameter intraluminal polypoid
hyperechoic mass in the gallbladder. Color Doppler ultra-
sonography examination demonstrated vessels in the
mid-portion of the mass. Computed tomography scan
confirmed the presence of a gallbladder tumor that
appeared as an enhancing pedunculated tumor within the
gallbladder, without thickening of the gallbladder wall.
The tumor seemed to be attached to the edge of the liver
with no macroscopic extension to the liver parenchyma
(Figure 1). Furthermore, TDM scan showed a cortical
fleshy nodule of the right kidney, measuring 2.2 cm, with
no involvement of the perinephric adipose (Figure 2). The
biliary symptoms and pedunculated appearance of the
tumor on the TDM scan suggested a possible diagnosis ofl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Axial computed tomography image after intravenous
contrast enhancement reveals an intraluminal pedunculated
hyperdense enhancing mass in the gallbladder without
thickening of the gallbladder wall.
Figure 2 Axial computed tomography image after intravenous
contrast enhancement shows a cortical fleshy nodule of the
right kidney with no involvement of the perinephric adipose.
Figure 3 Representative micrograph shows that the polyp is
composed of clear cell renal cell carcinoma in a background of
normal gallbladder (Hematoxylin-eosin, original magnification
x4).
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size of the renal nodule and the absence of urological
signs, a close monitoring of the renal lesion with a control
after 6 months was first advocated. The patient underwent
an open cholecystectomy with a partial liver resection.
The cholecystectomy specimen had a 4.0 × 3.0 × 2.0 cm,
dislodged polypoid mass free floating in the lumen of
the gallbladder. The surface of the mass was covered by
bile and necrotic debris. Cut surface of the mass was
homogenous, yellow-tan and soft, with foci of hemorrhage
and necrosis. The gallbladder mucosa was pale-tan and
slightly thickened. Grossly, no involvement of the gallblad-
der wall was identified. Gallstones were not found in the
bile. Histologically, the polyp consisted of clear cells with
delicate arborizing capillary vascular network, consistent
with a metastatic conventional clear cell renal cell carcin-
oma (Figure 3). Tumor cells were disposed in solid and
alveolar patterns. The cytoplasm was abundant, clear, and
surrounded by a distinct cell membrane. The nucleus was
round and uniform, with finely granular, evenly distributed
chromatin (Figure 4). There was no apparent involvement
of the gallbladder mucosa or the gallbladder wall. The
overlying mucosa showed no atypia or dysplasia. The
cystic duct resection margin was negative for carcinoma.
The liver parenchyma was not invaded by the carcinoma.
Diagnosis of metastatic renal cell carcinoma (RCC) wasconfirmed by immunohistochemical stains, which showed
the tumor cells to be positive for CD10 (Figure 5), vimentin
(Figure 6) and pancytokeratin, but negative for CK7, carci-
noembryonic antigen (CEA), chromogranin, synaptophysin
and CD68.
In light of these new data, the patient was transferred to
the department of Urology for a possible nephrectomy. A
right radical nephrectomy was carried out through right
subcostal incision without demonstrable vascular invasion
Figure 4 Representative micrograph of the polyp: The tumor is
composed of clear cells disposed in alveolar pattern with
delicate arborizing capillary vascular network.
(Hematoxylin-eosin, original magnification x10).
Figure 6 Immunohistochemical stain: The tumor cells are
positive for vimentin.
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operatively. On gross examination, the nephrectomy spe-
cimen showed a 2.2 cm yellowish cortical solid mass with
foci of hemorrhage. The histological study revealed a typ-
ical conventional clear cell RCC, Fuhrman nuclear grade
3, with negative surgical resection margins (Figure 7).
Discussion
Renal cell carcinomas (RCCs) represents on average over
90% of all malignancies of the kidney. Approximately
20%-30% of patients with RCC have metastatic disease
at presentation and nearly 50% of patients with advanced
disease die within 5 years of diagnosis. Global incidence
of RCC continues to grow steadily with the increase in
incidentally discovered lesions during imaging studies.
Up to 50%-60% of RCCs may be incidentally found in
asymptomatic patients at abdominal imaging studies
performed for other indications [4]. Recent advances inFigure 5 Immunohistochemical stain: The tumor cells are
positive for CD10.the understanding of the genetic basis of RCC have pro-
vided unique insights into the underlying histologic and
biological diversity of renal cancer. Renal cell carcinoma
is considered a byproduct of genetic events that may in-
volve gain-of-function of proto-oncogenes, loss-of-function
of cancer suppressor genes, or both [5]. Different histologic
subtypes of renal cell carcinoma have characteristic clinical,
genetic, and biological profiles. Indeed, the 2004 World
Health Organization recognizes that RCC is a clinicopatho-
logically heterogeneous malignant neoplasm that can be
classified into clear cell, papillary, chromophobe, collecting
duct, medullary carcinoma, and unclassified categories.
Clear cell RCC is the most common histologic subtype
representing 70%-75% of all RCCs. Papillary RCC andFigure 7 Clear cell renal cell carcinoma of the kidney
(Hematoxylin-eosin, original magnification x4).
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of the RCCs [6]. Distinct differences in biological behavior
and long-term prognosis among different subtypes of RCC
makes the correct histologic diagnosis critically important.
Clear cell RCC is characterized by glycogen and lipid-rich
clear cells within a regular network of small, thin-walled
blood vessels. Papillary RCC typically consists of papillae
containing a delicate fibrovascular core and covered by
epithelial cells. Chromophobe RCCs are histologically cha-
racterized by large polygonal pale cells with prominent cell
membranes and perinuclear clearing [6].
Clear cell RCC is characterized by its great propensity
to metastasize synchronously or metachronously to vari-
ous anatomic sites. Clear cell RCCs most commonly
metastasize hematogenously via the vena cava primarily
to the lung, although lymphatic metastases also occur.
Retrograde metastasis along the paravertebral veins, the
vena testicularis/vena ovarii, intra-renal veins, or along
the ureter may also occur [6]. The most common sites
of metastasis are the lung, bone, brain, liver, adrenal
gland, the other kidney, and rarely, organs such as the
vertebrae, stomach, spleen, pancreas, and diaphragm [7].
Clear cell RCC is well known for its propensity to
metastasize to unusual sites. Metastatic renal cell carcin-
oma in gallbladder is extremely rare. Indeed, the gallblad-
der was recognized as a site of metastasis in only 4 out
687 cases (0.58%) in large autopsy reviews [2]. Further-
more, metastatic gallbladder lesions are infrequent; mela-
noma, stomach, pancreas, ovary, canal bowel, biliary duct
and breast carcinomas are those that have the highest
probability of metastasis. Half of the cases are synchronic
[8]. To our knowledge, only 40 cases of metastatic renal cell
carcinoma in gallbladder were reported in the literature.
Clinical findings are not specific enough to arrive at a
final diagnosis. Metastatic tumors in gallbladder usually
appear in 39 to 84-year-old-males, who have a personal
history of cancer without previous biliary pathology,
while primary tumors prevail in women over 65 years of
age with biliary lithiasis [9]. In case of synchronous
gallbladder metastasis, the primary renal cell cancer is
found by TDM-scan who shows both lesions. However,
imaging diagnosis may not be conclusive in making a
differential diagnosis between primary and secondary
tumors. Ultrasonography is the initial approach in the
diagnosis of gallbladder tumors. Metastases can appear
under different hyperechoic masses bigger than 1 cm,
close to the gallbladder wall without posterior echogenic
shadowing [10]. Primary tumors appear as solid mass
occupying the entire wall thickness, or as a polypoid le-
sion with increased vascularization [10]. Invasion of the
mucosal layer is another radiological finding that can
help to differentiate between a primary gallbladder
tumor and metastasis in the computed tomography scan.
If the mucosa is not infiltrated, indicating an invasionfrom the serosa layer, the primary gallbladder tumor can
be excluded [10].
The pathologic study is the key of diagnosis. Macro-
scopically, reported metastatic renal cell carcinoma of
the gallbladder showed a single, intraluminal, polypoid
or pedunculated mass. In one reported case, like in our
case, the metastatic renal cell carcinoma was a free-
floating polyp within the lumen of the gallbladder with
no apparent involvement of the gallbladder wall [8]. The
clear cell RCC is typically golden yellow on cut surface,
due to the rich lipid content of its cells. Necrosis and
hemorrhage are commonly present. Microscopically, al-
most all cases showed clear cell renal carcinoma [8].
Clear cell RCC is architecturally diverse, with solid, al-
veolar and acinar pattern, the most common. The car-
cinomas typically contain a regular network of small
thin-walled blood vessels, a diagnostically helpful charac-
teristic of this tumor. The alveolar and acinar structures
may dilate, producing microcystic and macrocystic pat-
terns. Tumor cells have an abundant clear cytoplasm sur-
rounded by a distinct cell membrane. High grade tumors
may contain minority populations of cells with eosino-
philic cytoplasm. The nuclei tend to be round or uniform
with finely granular, evenly distributed chromatin. De-
pending upon the grade, nucleoli may be inconspicuous,
small, or large and prominent. Most clear cell RCCs have
little associated inflammatory response [6]. Metastatic
clear cell RCC in gallbladder is confirmed by immunohis-
tochemistry, using vimentin and CD10 in particular. In
our case, the tumor cells were positive for vimentin,
CD10, and pancytokeratin, but negative for CK7, CEA,
chromogranin, synaptophysin and CD68.
The specific diagnosis of polypoid gallbladder masses is
problematic. Because of the morphologic characteristics of
metastatic clear cell RCC in gallbladder, this tumor should
be distinguished from other polypoid lesions in the
gallbladder with clear cell morphology, including clear cell
carcinoma of gallbladder, clear cell carcinoid tumors, para-
gangliomas and cholesterol polyps. Clear cell morphology
is identical in both metastatic clear cell RCC and clear cell
carcinoma of gallbladder. Indeed, clear cell carcinomas of
the gallbladder are composed of clear cells arranged in
glands, sheets, nests, trabeculae and papillary structures.
The predominance in women and the presence of gall-
stones, mucin and other components, including conven-
tional adenocarcinomas, or squamous differentiation in
clear cell carcinoma helps depart a primitive clear cell car-
cinoma of gallbladder [9]. However, in some cases, only
immunohistochemical study can establish with certainty
the primitive or metastatic character of carcinoma. Indeed,
while some markers like broad spectrum cytokeratin and
epithelial membrane antigen (EMA) are expressed by both
tumor types, others are specific to one or the other. Thus,
vimentin and CD10 are expressed only in clear cell renal
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carcinomas [9]. In our case, tumor cells expressed vimen-
tin and CD10. Immunostaining with CEA was negative.
Metastatic clear cell RCC should also be differentiated
from a clear cell carcinoid tumor of the gallbladder. In the
latter, tumor cells arrange in nests and tubules within a
delicate capillary vascular network. However, they typically
invade through the muscular layer into perimuscular soft
tissue. Immunohistochemical stains are helpful in differen-
tiating metastatic clear cell RCC from clear cell carcinoid
tumor of the gallbladder. The latter is positive for neu-
roendocrine markers. Metastatic clear cell renal cell
carcinoma and clear cell carcinoma of the gallbladder are
negative for neuroendocrine markers [8]. Paraganglioma is
extremely rare in gallbladder. It appears as a small, well-
circumscribed nodule protruding to the external surface
of the gallbladder. The tumor is composed of chief and
sustentacular cells arranged in a zellballen pattern. Fur-
thermore, tumor cells in paraganglioma are positive for
neuroendocrine markers with positive staining for S100 in
the sustentacular cells [1]. Cholesterol polyps are small,
yellow, multilobulated polyps attached to the gallbladder
mucosa by a thin pedicle. Histologically, the tumor is
composed of foamy histiocytes covered by gallbladder mu-
cosa and lack the delicate arborizing capillary network
seen in clear cell renal carcinoma. These histiocytes are
positive for oil-red O and CD68 but negative for epithelial
markers by immunohistochemistry [1].
In all gallbladder findings with suspected malignancy, or
benign lesions larger than 1 cm, a cholecystectomy should
be performed to obtain a definitive diagnosis [11]. Chole-
cystectomy with R0 resection has been demonstrated to
be the only factor that increases survival mainly in isolated
cases of metastasis [8]. Synchronous metastasis of RCC in
the gallbladder at the time of nephrectomy does not
correlate with poor prognosis. Acute cholecystis as a
clinical presentation is associated with poor prognosis
[12]. The five-year survival rate following cholecystectomy
for RCC is 35-50%. According to Chung et al. [11], 63% of
patients with one gallbladder metastasis have a two-year
survival, while in the case of multiple metastases this rate
decreases to 23% following cholecystectomy.
Last case reports showed that solitary metastasis of
renal cell carcinoma in the gallbladder without evidence
of involvement of other anatomic sites correlated with
better survival [8]. Simple cholecystectomy for meta-
static renal cell carcinoma may provide favorable long-
term survival of patients with renal cell carcinoma [11].
Conclusion
In summary, we report a case of a free-floating intra-
luminal polyp of the gallbladder consistent with a meta-
static clear cell RCC and reviewed the 40 published cases
on metastatic renal cell carcinoma in the gallbladder inthe literature. This is the only case in which the renal cell
carcinoma was revealed by its metastasis in the gallblad-
der. The importance of histological and, especially, immu-
nohistochemical studies had been proven in distinguishing
metastatic clear cell carcinoma in the gallbladder from
other polypoid lesions of gallbladder with clear cell
morphology. This distinction was crucial for an optimal
management of both the gallbladder tumor and the primi-
tive renal carcinoma.
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